About 1,544 results

The Aerobika® OPEP device opens weak or collapsed airways to mobilize and assist mucociliary clearance to the upper airways where it can be coughed out. ... The Aerobika® OPEP device increases the natural process within the lungs to bring up mucus. ... The Aerobika® OPEP device provides ...

ADVAIR DISKUS (fluticasone propionate and salmeterol inhalation powder)

ADVAIR DISKUS is contraindicated for primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are ...

CYANOKIT® NB (hydroxocobalamin for injection)

INDICATION. CYANOKIT (hydroxocobalamin for injection) 5 g for intravenous infusion is indicated for the treatment of known or suspected cyanide poisoning. If clinical suspicion of cyanide poisoning is high, CYANOKIT should be administered without delay.

DALIRESP® (roflumilast)

Find out more about DALIRESP and how it may help patients with severe COPD that are already using bronchodilators. DALIRESP may reduce the risk of exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

BROVANA® (arformoterol tartrate) Inhalation Solution

Learn about BROVANA® (arformoterol tartrate), an inhaled maintenance treatment used with a nebulizer system for controlling symptoms of COPD.

COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray

COMBIVENT RESPIMAT is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to ...


The DrugRelief® percutaneous electrical nerve field stimulator (PNFS) is designed to administer auricular neurostimulation treatment ... Products & Applications.

INCRUSE ELLIPTA (umeclidinium inhalation powder) FOR ORAL INHALATION

Once-daily INCRUSE is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing.


Information for prescribers about the organizations and Surgeon General advice to co-prescribe naloxone to patients who will have opioids. Also includes the Surgeon General’s speech on opioids and co-prescribing naloxone.

GIAPREZA (angiotensin II)

GIAPREZA is the first and only FDA-approved synthetic human angiotensin II that increases blood pressure in adults with septic or other distributive shock. WHY GIAPREZA? Only GIAPREZA activates the RAAS system to increase MAP INCREASED MAP 70% of patients treated with GIAPREZA achieved target MAP at Hour 3 versus 23%


InspiraChamber with SootherMask, InspiraChamber is a Valved Holding Chamber (VHC) device that is used with metered dose inhalers to improve the delivery of medication to the lungs in the treatment of asthma and COPD.

MIVACRON® (mivacurium chloride)

MIVACRON® (mivacurium chloride) injection is a short-acting neuromuscular blocking agent indicated for inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Revonto® (dantrolene sodium for injection)

Revonto is ready to administer in 20 seconds or until the solution is clear. ... difference between life and death. Reverse the crisis with Revonto ...


Every year Hydralyte provides thousands of medical professionals with educational materials on rehydration, coupons, and product samples for patients.

ANORO® ELLIPTA® (umeclidinium bromide/vilanterol)

ANORO ELLIPTA, umeclidinium 62.5 mcg and vilanterol 25 mcg inhalation powder, is for the once-daily maintenance treatment of airflow obstruction in patients with COPD. ANORO is NOT for the relief of acute bronchospasm or for asthma.

AVYCAZ® (ceftazidime and avibactam)

Healthcare professionals, find information about AVYCAZ® (ceftazidime and avibactam). See the Phase 3 clinical data in HABP/VABP, cUTI, and cIAI.

BEVESPI AEROSPHERE® (glycopyrrolate/formoterol fumarate)

BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) is a long?term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.

BEVESPI AEROSPHERE® CO-SUSPENSION TECHNOLOGY (glycopyrrolate/formoterol fumarate)

BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) is a long?term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.

CREON® (pancrelipase)

Patients with exocrine pancreatic insufficiency (EPI) due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions cannot properly digest food due to a lack of pancreatic digestive enzymes. CREON replaces those enzymes, helping patients absorb more nutritional value from the foods they eat.

CETYLEV® (acetylcysteine)

Hypersensitivity reactions, including generalized urticaria have been observed in patients receiving oral acetylcysteine overdose. If hypersensitivity reactions occur, Cetylev should be discontinued unless it is deemed essential for patient management and the reactions can be otherwise controlled.